Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Cost of illness of epilepsy in the US: comparison of patient-based and population-based estimates.

Halpern M, Rentz A, Murray M.

Neuroepidemiology. 2000 Mar-Apr;19(2):87-99.

PMID:
10686533
2.

Cost of disorders of the brain in Europe 2010.

Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, Dodel R, Ekman M, Faravelli C, Fratiglioni L, Gannon B, Jones DH, Jennum P, Jordanova A, Jönsson L, Karampampa K, Knapp M, Kobelt G, Kurth T, Lieb R, Linde M, Ljungcrantz C, Maercker A, Melin B, Moscarelli M, Musayev A, Norwood F, Preisig M, Pugliatti M, Rehm J, Salvador-Carulla L, Schlehofer B, Simon R, Steinhausen HC, Stovner LJ, Vallat JM, Van den Bergh P, van Os J, Vos P, Xu W, Wittchen HU, Jönsson B, Olesen J; CDBE2010Study Group.

Eur Neuropsychopharmacol. 2011 Oct;21(10):718-79. doi: 10.1016/j.euroneuro.2011.08.008. Epub 2011 Sep 15. Erratum in: Eur Neuropsychopharmacol. 2012 Mar;22(3):237-8. den Bergh, Peter Van [corrected to Van den Bergh, Peter].

PMID:
21924589
3.

The cost of epilepsy in the United States: an estimate from population-based clinical and survey data.

Begley CE, Famulari M, Annegers JF, Lairson DR, Reynolds TF, Coan S, Dubinsky S, Newmark ME, Leibson C, So EL, Rocca WA.

Epilepsia. 2000 Mar;41(3):342-51.

4.

Cost of epilepsy in the United States: a model based on incidence and prognosis.

Begley CE, Annegers JF, Lairson DR, Reynolds TF, Hauser WA.

Epilepsia. 1994 Nov-Dec;35(6):1230-43.

PMID:
7988516
5.

A comparison of two methods for estimating the health care costs of epilepsy.

Frost FJ, Hurley JS, Petersen HV, Gunter MJ, Gause D.

Epilepsia. 2000 Aug;41(8):1020-6.

6.

Economic differences in direct and indirect costs between people with epilepsy and without epilepsy.

Libby AM, Ghushchyan V, McQueen RB, Slejko JF, Bainbridge JL, Campbell JD.

Med Care. 2012 Nov;50(11):928-33. doi: 10.1097/MLR.0b013e31826c8613.

PMID:
23047781
7.

The costs of childhood epilepsy in Italy: comparative findings from three health care settings.

Guerrini R, Battini R, Ferrari AR, Veggiotti P, Besana D, Gobbi G, Pezzani M, Berta E, Tetto A, Beghi E, Monticelli ML, Tediosi F, Garattini L, Russo S, Rasmini P, Amadi A, Quarti P, Fabrizzi R; Epilepsy Collaborative Study Group.

Epilepsia. 2001 May;42(5):641-6.

8.

Economic burden of epilepsy in a developing country: a retrospective cost analysis in China.

Hong Z, Qu B, Wu XT, Yang TH, Zhang Q, Zhou D.

Epilepsia. 2009 Oct;50(10):2192-8. doi: 10.1111/j.1528-1167.2009.02185.x. Epub 2009 Jul 2.

9.

Economic evaluation of seizures associated with solitary cysticercus granuloma.

Murthy JM, Rajshekar G.

Neurol India. 2007 Jan-Mar;55(1):42-5.

10.

Estimating the cost of epilepsy in Europe: a review with economic modeling.

Pugliatti M, Beghi E, Forsgren L, Ekman M, Sobocki P.

Epilepsia. 2007 Dec;48(12):2224-33. Review.

11.

Direct medical cost of children and adolescents epilepsy at a university setting in Croatia.

Prpić I, Boban M, Skarpa-Prpić I, Jurjević A, Babić T, Fiket D.

Coll Antropol. 2009 Jun;33(2):503-8.

PMID:
19662770
12.

Economic burden of epilepsy in India.

Thomas SV, Sarma PS, Alexander M, Pandit L, Shekhar L, Trivedi C, Vengamma B.

Epilepsia. 2001 Aug;42(8):1052-60.

13.

Economic costs of diabetes in the US in 2002.

Hogan P, Dall T, Nikolov P; American Diabetes Association.

Diabetes Care. 2003 Mar;26(3):917-32.

PMID:
12610059
14.

Early treatment cost in epilepsy and how it varies with seizure type and frequency.

Begley CE, Lairson DR, Reynolds TF, Coan S.

Epilepsy Res. 2001 Dec;47(3):205-15.

PMID:
11738928
15.

Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans.

White RR, Lenhart G, Singhal PK, Insinga RP, Itzler RF, Pellissier JM, Segraves AW.

Pharmacoeconomics. 2009;27(9):781-92. doi: 10.2165/11317560-000000000-00000.

PMID:
19757871
16.

Economic burden of schizophrenia: empirical analyses from a survey in Thailand.

Phanthunane P, Whiteford H, Vos T, Bertram M.

J Ment Health Policy Econ. 2012 Mar;15(1):25-32.

PMID:
22611090
17.

Cost-of-illness of epilepsy in Italy. Data from a multicentre observational study (Episcreen).

Berto P, Tinuper P, Viaggi S.

Pharmacoeconomics. 2000 Feb;17(2):197-208.

PMID:
10947342
18.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
19.

Trends in the cost of illness for asthma in the United States, 1985-1994.

Weiss KB, Sullivan SD, Lyttle CS.

J Allergy Clin Immunol. 2000 Sep;106(3):493-9.

PMID:
10984369
20.

Estimating the costs of epilepsy: an international comparison of epilepsy cost studies.

Kotsopoulos IA, Evers SM, Ament AJ, de Krom MC.

Epilepsia. 2001 May;42(5):634-40. Review.

Supplemental Content

Support Center